Charles River Laboratories (CRL) Tops Q4 EPS by 15c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Charles River Labs (CRL) PT Lowered to $115 at Evercore ISI
February 13, 2018 12:28 PM ESTEvercore ISI lowered its price target on Charles River Labs (NYSE: CRL) to $115.00 (from $117.00) while maintaining a In Line rating.
The firm lowered FY18 EPS from $5.80 to $5.75, FY19 from $6.55 to $6.45 and FY20 from $7.50 to $7.15.
... More